FDA Inspection
Lonza Bend IncLonza Bend Inc – FDA Inspection, Jul 27, 2018
Record Details
This FDA Inspection record concerns Lonza Bend Inc, with an inspection on July 27, 2018, issued by the Seattle District Office, covering human drugs.
View Company Profile
ID · c76c00f8-e2a1-4545-ac99-a0d4e175830a
Inspection Facts
- Inspection number
- 1060951
- FDA center
- Human Drugs
- Project area
- New Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.165(e)Test methods
- 21 CFR 211.166(a)(3)Valid stability test methods
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lonza Bend Inc
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 5, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 30, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 3, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lonza Bend Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.